Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-417919

Chief Executive Officer sold 4,522 shares at an average $31.68 ($143,273)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ceesay Abraham · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-06 Sale : show line 1 in the form 10b5-1 −3,375 $32.03 $108,106 453,392 D
2026-10-07 Sale : show line 2 in the form 10b5-1 −1,147 $30.66 $35,167 452,245 D
Open-market sales · 4,522 sh · avg $31.68 · $143,273
Loading xslF345X06/ownership.xml…